The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report
| Autor: | Vyacheslav Grechkin, A. V Budnevsky, Roman Tokmachev, Igor Banin, Inessa Savushkina, Evgeniy Ovsyannikov, Oleg Neznamov |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
2019-20 coronavirus outbreak
medicine.medical_specialty pulmonary surfactant Lung General Immunology and Microbiology Coronavirus disease 2019 (COVID-19) business.industry General Neuroscience Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) macromolecular substances medicine.disease Surfactant therapy General Biochemistry Genetics and Molecular Biology Pneumonia medicine.anatomical_structure covid-19 medicine pneumonia Medicine Effective treatment Intensive care medicine business Biomedicine |
| Zdroj: | International Journal of Biomedicine, Vol 11, Iss 2, Pp 177-180 (2021) |
| ISSN: | 2158-0529 2158-0510 |
| DOI: | 10.21103/article11(2)_cr1 |
| Popis: | The COVID-19 pandemic has presented challenges to finding effective treatment for lung damage. Medical researchers from different countries recognize the deficiency of pulmonary surfactant (PS) as a significant cause of the alveolar collapse, followed by microatelectasis and severe disturbances in the ventilation-perfusion relationship. Due to the pathophysiological rationale, experimental confirmations, and accumulated clinical experience, the PS preparations can be used to treat patients with severe COVID-19. The article provides a description of a case when surfactant therapy was successfully used in a patient with severe COVID-19 pneumonia.(International Journal of Biomedicine. 2021;11(2):177-180.). © 2021, International Medical Research and Development Corporation. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|